{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:20:05Z","timestamp":1790875205347,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","award":["OT123-391"],"award-info":[{"award-number":["OT123-391"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 2254 HEIST"],"award-info":[{"award-number":["GRK 2254 HEIST"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neo.2023.100884","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T13:51:09Z","timestamp":1676901069000},"page":"100884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-1206","authenticated-orcid":false,"given":"Tobias","family":"Kolb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-1464","authenticated-orcid":false,"given":"Julian","family":"Benckendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.E.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-1429","authenticated-orcid":false,"given":"Ralf B.","family":"Marienfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0001","first-page":"7","article-title":"\"Cancer statistics, 2021\"","volume":"Bd. 71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"Nr. 2","key":"10.1016\/j.neo.2023.100884_bib0002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ro.2005.01.001","article-title":"The 2004 World health organization classification of lung tumors","volume":"40","author":"Beasley","year":"2005","journal-title":"Semin. Roentgenol."},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0003","first-page":"5","article-title":"Adenocarcinoma classification: patterns and prognosis","volume":"110","author":"Kuhn","year":"2018","journal-title":"Pathologica"},{"issue":"Nr. 9","key":"10.1016\/j.neo.2023.100884_bib0004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"Russell","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"Nr. 8","key":"10.1016\/j.neo.2023.100884_bib0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0b013e3181e4ee32","article-title":"A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors","volume":"34","author":"Sica","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"Nr. 7","key":"10.1016\/j.neo.2023.100884_bib0006","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2007-11-123141","article-title":"B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells","volume":"111","author":"Azuma","year":"2008","journal-title":"Blood"},{"issue":"Nr. 11","key":"10.1016\/j.neo.2023.100884_bib0007","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"Nr. 3","key":"10.1016\/j.neo.2023.100884_bib0008","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"Nr. 2","key":"10.1016\/j.neo.2023.100884_bib0009","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"Nr. 6","key":"10.1016\/j.neo.2023.100884_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.neo.2021.05.005","article-title":"Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma","volume":"23","author":"M\u00fcller","year":"2021","journal-title":"Neoplasia"},{"issue":"Nr. 26","key":"10.1016\/j.neo.2023.100884_bib0011","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of Anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"Nr. Suppl 4","key":"10.1016\/j.neo.2023.100884_bib0013","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"issue":"Nr. 2","key":"10.1016\/j.neo.2023.100884_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"Nr. 17","key":"10.1016\/j.neo.2023.100884_bib0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2012.43.1718","article-title":"Use of research biopsies in clinical trials: are risks and benefits adequately discussed?","volume":"31","author":"Overman","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"Nr. 12","key":"10.1016\/j.neo.2023.100884_bib0017","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neo.2021.10.001","article-title":"Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing","volume":"23","author":"Li","year":"2021","journal-title":"Neoplasia"},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0018","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12885-019-5578-4","article-title":"Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12885-016-2049-z","article-title":"Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"issue":"Nr. 2","key":"10.1016\/j.neo.2023.100884_bib0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"Harjunp\u00e4\u00e4","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"Nr. 8","key":"10.1016\/j.neo.2023.100884_bib0021","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/eji.201243072","article-title":"Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR","volume":"43","author":"Stanietsky","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"Nr. 8","key":"10.1016\/j.neo.2023.100884_bib0022","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/modpathol.2012.58","article-title":"A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"issue":"Nr. 1","key":"10.1016\/j.neo.2023.100884_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/JTO.0b013e318276274e","article-title":"Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system","volume":"8","author":"von der Th\u00fcsen","year":"2013","journal-title":"J. Thorac. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.neo.2026.101364","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862300009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862300009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:38:12Z","timestamp":1778816292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655862300009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"alternative-id":["S147655862300009X"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2023.100884","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2023.100884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100884"}}